Page last updated: 2024-08-21

cyproterone acetate and 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile

cyproterone acetate has been researched along with 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaillard, M; Matias, JR1
André, J; Foury, O; Joly-Pharaboz, MO; Nicolas, B1

Other Studies

2 other study(ies) available for cyproterone acetate and 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile

ArticleYear
Local inhibition of sebaceous gland growth by topically applied RU 58841.
    Annals of the New York Academy of Sciences, 1995, Jun-12, Volume: 761

    Topics: Administration, Topical; Androgen Antagonists; Animals; Cricetinae; Cyproterone Acetate; Ear; Imidazoles; Indenes; Male; Mesocricetus; Models, Biological; Nitriles; Sebaceous Glands; Structure-Activity Relationship; Time Factors

1995
Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responses.
    The Journal of steroid biochemistry and molecular biology, 1998, Volume: 66, Issue:4

    Topics: Androgen Antagonists; Cell Division; Cyproterone Acetate; Genes, myc; Humans; Imidazoles; Kinetics; Male; Metribolone; Nitriles; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; RNA, Messenger; Testosterone Congeners; Transcription, Genetic; Tumor Cells, Cultured

1998